Recommendations for the medication of rheumatic diseases in periconceptional period
10.3760/cma.j.cn112138-20210527-00372
- VernacularTitle:风湿性疾病患者围妊娠期药物使用规范
- Author:
Wen ZHANG
1
;
Yisha LI
;
Dongzhou LIU
;
Juan LI
;
Juan SU
;
Li WANG
;
Zhuoli ZHANG
;
Xiaoxia ZUO
;
Yan ZHAO
Author Information
1. 中国医学科学院 北京协和医学院 北京协和医院风湿免疫科 国家皮肤与免疫疾病临床医学研究中心 疑难重症及罕见病国家重点实验室 风湿免疫病学教育部重点实验室 100730
- Keywords:
Rheumatic diseases;
Periconceptional period;
Treatment
- From:
Chinese Journal of Internal Medicine
2021;60(11):946-953
- CountryChina
- Language:Chinese
-
Abstract:
Rheumatic diseases are a kind of chronic inflammatory diseases mainly involving joints and surrounding tissues. Most patients with rheumatic diseases need long-term treatment, which is difficult to be avoided during pregnancy. Treatment efficacy, as well as maternal and fetal safety should be taken into account in the medical decision. Based on the domestic and foreign guidelines, consensus, diagnosis and treatment experience, Chinese Rheumatology Association developed the standardization of medication use in patients with rheumatic diseases preparing and during pregnancy, aiming on the application and precautions of commonly used medicines for rheumatic diseases in preparing pregnancy, pregnancy and lactation.
